Fast track assessment facilities can contribute to timely evaluation of lung malignancies

NewsGuard 100/100 Score

Research published in the October 2009 issue of the Journal of Thoracic Oncology has found an effective combination of positron emission tomography (PET)/computed tomography (CT) (PET/CT) tests to diagnose lung cancer in a "fast-tracked" outpatient setting. This novel approach to the diagnosis of lung cancer demonstrated a high level of sensitivity (97%) and accuracy (82%). The fast track model tests patients for lung cancer over the course of one day and could expedite identification and treatment of the disease.

Using the 18F-fluorodeoxyglucose (FDG) imaging technique,with a PET/CT scanner, researchers from The Netherlands Cancer Institute in Amsterdam evaluated 114 patients experiencing pulmonary symptoms and/or abnormal chest x-rays.

Researchers were able to make a final diagnosis for 92 percent of the patients using the fast-tracked model, and determine a malignancy in 84 percent of the patients. These results represent a diagnostic gain of 8 and 7 percent respectively compared to previous techniques.

"Our approach resulted in a fast and accurate diagnosis and allowed for treatment to be initiated without delays." said Dr. Tjeerd S. Aukema of The Netherlands Cancer Institute. "These results suggest that availability of fast track assessment facilities can contribute to appropriate and timely evaluation of lung malignancies."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer